FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020105159> ?p ?o ?g. }

• W2020105159 endingPage "833" @default.
• W2020105159 startingPage "820" @default.
• W2020105159 abstract "The PI3K/Akt/mTORC1 pathway plays prominent roles in malignant transformation, prevention of apoptosis, drug resistance, and metastasis. One molecule regulated by this pathway is GSK-3β. GSK-3β is phosphorylated by Akt on S9, which leads to its inactivation; however, GSK-3β also can regulate the activity of the PI3K/Akt/mTORC1 pathway by phosphorylating molecules such as PTEN, TSC2, p70S6K, and 4E-BP1. To further elucidate the roles of GSK-3β in chemotherapeutic drug and hormonal resistance of MCF-7 breast cancer cells, we transfected MCF-7 breast cancer cells with wild-type (WT), kinase-dead (KD), and constitutively activated (A9) forms of GSK-3β. MCF-7/GSK-3β(KD) cells were more resistant to doxorubicin and tamoxifen compared with either MCF-7/GSK-3β(WT) or MCF-7/GSK-3β(A9) cells. In the presence and absence of doxorubicin, the MCF-7/GSK-3β(KD) cells formed more colonies in soft agar compared with MCF-7/GSK-3β(WT) or MCF-7/GSK-3β(A9) cells. In contrast, MCF-7/GSK-3β(KD) cells displayed an elevated sensitivity to the mTORC1 blocker rapamycin compared with MCF-7/GSK-3β(WT) or MCF-7/GSK-3β(A9) cells, while no differences between the 3 cell types were observed upon treatment with a MEK inhibitor by itself. However, resistance to doxorubicin and tamoxifen were alleviated in MCF-7/GSK-3β(KD) cells upon co-treatment with an MEK inhibitor, indicating regulation of this resistance by the Raf/MEK/ERK pathway. Treatment of MCF-7 and MCF-7/GSK-3β(WT) cells with doxorubicin eliminated the detection of S9-phosphorylated GSK-3β, while total GSK-3β was still detected. In contrast, S9-phosphorylated GSK-3β was still detected in MCF-7/GSK-3β(KD) and MCF-7/GSK-3β(A9) cells, indicating that one of the effects of doxorubicin on MCF-7 cells was suppression of S9-phosphorylated GSK-3β, which could result in increased GSK-3β activity. Taken together, these results demonstrate that introduction of GSK-3β(KD) into MCF-7 breast cancer cells promotes resistance to doxorubicin and tamoxifen, but sensitizes the cells to mTORC1 blockade by rapamycin. Therefore GSK-3β is a key regulatory molecule in sensitivity of breast cancer cells to chemo-, hormonal, and targeted therapy." @default.
• W2020105159 created "2016-06-24" @default.
• W2020105159 creator A5004270101 @default.
• W2020105159 creator A5010041881 @default.
• W2020105159 creator A5030391285 @default.
• W2020105159 creator A5033627041 @default.
• W2020105159 creator A5068920075 @default.
• W2020105159 creator A5090657536 @default.
• W2020105159 creator A5091807722 @default.
• W2020105159 date "2014-01-09" @default.
• W2020105159 modified "2023-10-17" @default.
• W2020105159 title "Inhibition of GSK-3β activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in MCF-7 breast cancer cells" @default.
• W2020105159 cites W1529336528 @default.
• W2020105159 cites W1539742558 @default.
• W2020105159 cites W1545398558 @default.
• W2020105159 cites W1555772346 @default.
• W2020105159 cites W1559573079 @default.
• W2020105159 cites W1569244981 @default.
• W2020105159 cites W1754519356 @default.
• W2020105159 cites W1869563671 @default.
• W2020105159 cites W1884687252 @default.
• W2020105159 cites W1908612571 @default.
• W2020105159 cites W1918395140 @default.
• W2020105159 cites W1966478556 @default.
• W2020105159 cites W1966611829 @default.
• W2020105159 cites W1972986619 @default.
• W2020105159 cites W1974949037 @default.
• W2020105159 cites W1981756966 @default.
• W2020105159 cites W1982102717 @default.
• W2020105159 cites W1983055247 @default.
• W2020105159 cites W1987423659 @default.
• W2020105159 cites W1987822201 @default.
• W2020105159 cites W1990201193 @default.
• W2020105159 cites W1995125154 @default.
• W2020105159 cites W1997224330 @default.
• W2020105159 cites W1999876234 @default.
• W2020105159 cites W2000324903 @default.
• W2020105159 cites W2017249583 @default.
• W2020105159 cites W2017879596 @default.
• W2020105159 cites W2023164162 @default.
• W2020105159 cites W2023887187 @default.
• W2020105159 cites W2028642586 @default.
• W2020105159 cites W2035114699 @default.
• W2020105159 cites W2038073573 @default.
• W2020105159 cites W2040061273 @default.
• W2020105159 cites W2047197367 @default.
• W2020105159 cites W2047537157 @default.
• W2020105159 cites W2049638120 @default.
• W2020105159 cites W2058138221 @default.
• W2020105159 cites W2058783987 @default.
• W2020105159 cites W2073491859 @default.
• W2020105159 cites W2074883812 @default.
• W2020105159 cites W2076203883 @default.
• W2020105159 cites W2077061070 @default.
• W2020105159 cites W2078131701 @default.
• W2020105159 cites W2083993197 @default.
• W2020105159 cites W2085617376 @default.
• W2020105159 cites W2091240925 @default.
• W2020105159 cites W2093255506 @default.
• W2020105159 cites W2102807979 @default.
• W2020105159 cites W2103885797 @default.
• W2020105159 cites W2105124338 @default.
• W2020105159 cites W2105246953 @default.
• W2020105159 cites W2114594254 @default.
• W2020105159 cites W2116343320 @default.
• W2020105159 cites W2119924449 @default.
• W2020105159 cites W2126099199 @default.
• W2020105159 cites W2126244179 @default.
• W2020105159 cites W2130143704 @default.
• W2020105159 cites W2133540186 @default.
• W2020105159 cites W2164213562 @default.
• W2020105159 cites W2168142258 @default.
• W2020105159 cites W2168336823 @default.
• W2020105159 cites W65155625 @default.
• W2020105159 cites W4293242696 @default.
• W2020105159 doi "https://doi.org/10.4161/cc.27728" @default.
• W2020105159 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3979918" @default.
• W2020105159 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24407515" @default.
• W2020105159 hasPublicationYear "2014" @default.
• W2020105159 type Work @default.
• W2020105159 sameAs 2020105159 @default.
• W2020105159 citedByCount "40" @default.
• W2020105159 countsByYear W20201051592014 @default.
• W2020105159 countsByYear W20201051592015 @default.
• W2020105159 countsByYear W20201051592016 @default.
• W2020105159 countsByYear W20201051592017 @default.
• W2020105159 countsByYear W20201051592018 @default.
• W2020105159 countsByYear W20201051592019 @default.
• W2020105159 countsByYear W20201051592020 @default.
• W2020105159 countsByYear W20201051592021 @default.
• W2020105159 countsByYear W20201051592022 @default.
• W2020105159 crossrefType "journal-article" @default.
• W2020105159 hasAuthorship W2020105159A5004270101 @default.
• W2020105159 hasAuthorship W2020105159A5010041881 @default.
• W2020105159 hasAuthorship W2020105159A5030391285 @default.
• W2020105159 hasAuthorship W2020105159A5033627041 @default.
• W2020105159 hasAuthorship W2020105159A5068920075 @default.
• W2020105159 hasAuthorship W2020105159A5090657536 @default.

• next